TARDBP and amyotrophic lateral sclerosis: Because cytoplasmic TDP-43 aggregates accompanied by a loss of nuclear TDP-43 have been found in ALS patients, a major unresolved question regarding TDP-43-mediated neurodegeneration is that whether the toxicity is triggered by a toxic gain-of-function or by a loss-of-function.